ARCEDI BIOTECH ApS — Credit Rating and Financial Key Figures
CVR number: 25577922
Tabletvej 1, 7100 Vejle
tel: 49288888
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 4 903.00 | 3 864.00 | -8 906.00 | -7 228.00 | -12 655.00 |
| Employee benefit expenses | -9 357.00 | -10 403.00 | -13 873.00 | -16 436.00 | -16 012.00 |
| Total depreciation | -95.00 | -95.00 | -6 789.00 | -8 228.00 | -8 792.00 |
| EBIT | -4 549.00 | -6 634.00 | -29 568.00 | -31 892.00 | -37 459.00 |
| Other financial income | 1.00 | 35.00 | 7.00 | 46.00 | 47.00 |
| Other financial expenses | -1 768.00 | -2 281.00 | -3 675.00 | -10 370.00 | -13 302.00 |
| Pre-tax profit | -6 316.00 | -8 880.00 | -33 236.00 | -42 216.00 | -50 714.00 |
| Income taxes | 2 463.00 | 3 101.00 | 9 035.00 | 9 745.00 | 8 753.00 |
| Net earnings | -3 853.00 | -5 779.00 | -24 201.00 | -32 471.00 | -41 961.00 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 88 322.00 | 106 802.00 | 103 816.00 | 109 700.00 | 108 805.00 |
| Intangible rights | 7 117.00 | 7 897.00 | 7 988.00 | ||
| Intangible assets total | 88 322.00 | 106 802.00 | 110 933.00 | 117 597.00 | 116 793.00 |
| Buildings | 237.00 | 142.00 | 4 541.00 | 7 518.00 | 6 833.00 |
| Advance payments and construction in progress | 1 142.00 | ||||
| Tangible assets total | 237.00 | 142.00 | 5 683.00 | 7 518.00 | 6 833.00 |
| Investments total | |||||
| Long term receivables total | |||||
| Raw materials and consumables | 808.00 | 1 622.00 | |||
| Inventories total | 808.00 | 1 622.00 | |||
| Current trade debtors | 54.00 | 252.00 | 127.00 | 398.00 | |
| Prepayments and accrued income | 5.00 | 77.00 | 183.00 | 832.00 | 1 660.00 |
| Current other receivables | 1 493.00 | 1 534.00 | 2 677.00 | 2 888.00 | 2 905.00 |
| Current deferred tax assets | 3 581.00 | 3 826.00 | 5 154.00 | 5 734.00 | 4 439.00 |
| Short term receivables total | 5 079.00 | 5 491.00 | 8 266.00 | 9 581.00 | 9 402.00 |
| Cash and bank deposits | 945.00 | 2 486.00 | 1 537.00 | 1 649.00 | 1 270.00 |
| Cash and cash equivalents | 945.00 | 2 486.00 | 1 537.00 | 1 649.00 | 1 270.00 |
| Balance sheet total (assets) | 94 583.00 | 114 921.00 | 126 419.00 | 137 153.00 | 135 920.00 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Other reserves | 56 711.00 | 70 143.00 | 71 640.00 | 76 765.00 | 76 602.00 |
| Retained earnings | -76 284.00 | -93 569.00 | - 100 845.00 | - 130 171.00 | - 162 479.00 |
| Profit of the financial year | -3 853.00 | -5 779.00 | -24 201.00 | -32 471.00 | -41 961.00 |
| Shareholders equity total | -23 346.00 | -29 125.00 | -53 326.00 | -85 797.00 | - 127 758.00 |
| Provisions | 11 715.00 | 12 440.00 | 8 559.00 | 4 548.00 | |
| Non-current owed to group member | 164 864.00 | 211 217.00 | 259 008.00 | ||
| Non-current liabilities total | 164 864.00 | 211 217.00 | 259 008.00 | ||
| Current trade creditors | 2 433.00 | 1 977.00 | 5 582.00 | 5 797.00 | 3 956.00 |
| Current owed to participating | 18 128.00 | 18 493.00 | |||
| Other non-interest bearing current liabilities | 85 048.00 | 111 136.00 | 740.00 | 1 388.00 | 714.00 |
| Accruals and deferred income | 605.00 | ||||
| Current liabilities total | 106 214.00 | 131 606.00 | 6 322.00 | 7 185.00 | 4 670.00 |
| Balance sheet total (liabilities) | 94 583.00 | 114 921.00 | 126 419.00 | 137 153.00 | 135 920.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.